Scientists from Roswell Park Comprehensive Cancer Center have shed light on a different way of overcoming mechanisms of resistance to specific therapeutic agents used to treat cancer. In a new article published March 1 in ...
Mar 3, 2022
0
88
Sanger researchers have created the world's largest novel resource using systematic drug testing and genetics analyses to show new potential drug combinations for breast, colon, and pancreatic cancer.
Feb 24, 2022
0
119
Researchers created stable cell lines capable of producing different genotypes of the hepatitis B virus (HBV), advancing understanding of each type's distinct virological features, treatment responses, and infectivity that ...
Feb 14, 2022
0
39
Drugs which are commonly used as the first line of treatment for colorectal cancer cause the tumor cells to oversecrete proteins known as mucins, according to a new study published today in the journal eLife. The proteins ...
Feb 8, 2022
0
7
Scientists in Barcelona have today launched GENIGMA, a videogame that enlists players to solve puzzles while generating real-world scientific data that can detect alterations in genomic sequences and ultimately advance breast ...
Jan 27, 2022
0
17
How can you mend a broken heart? According to researchers from Japan, in some cases gene replacement therapy just might do the trick.
Jan 24, 2022
0
4
There are millions of mutations and other genetic variations in cancer. Understanding which of these mutations is an impactful tumor "driver" compared to an innocuous "passenger," and what each of the drivers does to the ...
Jan 21, 2022
0
58
Understanding how the brain develops is crucial to formulating treatments and management protocols for a variety of developmental disorders, as well as degenerative neurological diseases. Right from the embryonic stage, brain ...
Jan 11, 2022
0
5
Experiments attempting to explain why bats can be infected with many viruses at a time without succumbing to diseases such as COVID-19—knowledge that could help us to reduce the threat to humans of infectious disease—have ...
Dec 29, 2021
0
308
Newly designed chimeric antigen receptor (CAR) T-cells targeting the CD19 antigen are effective in treating adults and children with B-cell malignancies, especially when produced under place-of-care manufacturing which is ...
Dec 20, 2021
0
3
